Perrigo ROE 2006-2019 | PRGO

Current and historical return on equity (ROE) values for Perrigo (PRGO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Perrigo ROE for the three months ending March 31, 2019 was 10.40%.
Perrigo ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.11B $5.70B 1.99%
2018-12-31 $0.13B $5.67B 2.24%
2018-09-30 $0.12B $5.66B 2.04%
2018-06-30 $0.24B $5.90B 3.87%
2018-03-31 $0.13B $6.21B 2.11%
2017-12-31 $0.12B $6.17B 1.97%
2017-09-30 $-1.31B $6.04B -21.73%
2017-06-30 $-2.95B $6.08B -46.07%
2017-03-31 $-3.41B $6.07B -47.78%
2016-12-31 $-4.01B $5.96B -49.82%
2016-09-30 $-2.83B $7.48B -31.10%
2016-06-30 $-0.98B $9.05B -9.86%
2016-03-31 $-0.46B $9.73B -4.50%
2015-12-31 $0.04B $10.11B 0.42%
2015-09-30 $0.29B $10.73B 2.82%
2015-06-30 $0.12B $10.66B 1.26%
2014-12-31 $0.21B $9.72B 2.40%
2014-09-30 $0.06B $8.72B 0.67%
2013-12-31 $0.14B $8.50B 3.53%
2013-09-30 $0.33B $2.47B 14.40%
2012-12-31 $0.33B $2.11B 17.04%
2012-09-30 $0.32B $1.97B 17.83%
2011-12-31 $0.26B $1.63B 16.90%
2011-09-30 $0.25B $1.54B 17.15%
2010-12-31 $0.23B $1.31B 19.38%
2010-09-30 $0.20B $1.21B 18.14%
2009-12-31 $0.16B $0.99B 17.12%
2009-09-30 $0.12B $0.96B 13.85%
2008-12-31 $0.10B $0.83B 11.74%
2008-09-30 $0.11B $0.89B 12.80%
2007-12-31 $0.09B $0.82B 11.16%
2007-09-30 $0.07B $0.77B 9.86%
2006-12-31 $0.06B $0.69B 9.01%
2006-09-30 $0.06B $0.66B 9.95%
2005-12-31 $-0.34B $0.61B -56.86%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.039B $4.732B
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.050B 28.74
Medtronic (MDT) Ireland $133.110B 19.01
Stryker (SYK) United States $77.009B 27.48
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $41.655B 26.25
EssilorLuxottica Societe Anonyme (ESLOY) France $29.025B 0.00
Coloplast (CLPBY) Denmark $25.553B 40.79
Zimmer Biomet Holdings (ZBH) United States $24.699B 15.87
Lonza Group Ag (LZAGY) Switzerland $24.641B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.003B 0.00
ResMed (RMD) United States $17.837B 34.08
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Canopy Growth (CGC) Canada $11.829B 0.00
Bio-Rad Laboratories (BIO) United States $9.215B 48.85
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.176B 522.83
Hill-Rom Holdings (HRC) United States $6.945B 21.06
Aurora Cannabis (ACB) Canada $6.865B 67.70
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.279B 51.26
GW Pharmaceuticals (GWPH) United Kingdom $5.201B 0.00
ICU Medical (ICUI) United States $5.129B 30.60
Neogen (NEOG) United States $3.284B 53.39
NuVasive (NUVA) United States $2.961B 24.18
Hutchison China MediTech (HCM) China $2.957B 0.00
Agios Pharmaceuticals (AGIO) United States $2.654B 0.00
National Vision Holdings (EYE) United States $2.458B 52.37
Quidel (QDEL) United States $2.284B 23.70
Aphria (APHA) $1.561B 0.00
Cardiovascular Systems (CSII) United States $1.537B 882.60
Phibro Animal Health (PAHC) United States $1.234B 18.49
AtriCure (ATRC) United States $1.212B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.92
Lantheus Holdings (LNTH) United States $1.078B 28.62
NanoString Technologies (NSTG) United States $1.036B 0.00
PetIQ (PETQ) United States $0.971B 23.59
MacroGenics (MGNX) United States $0.775B 0.00
Omeros (OMER) United States $0.770B 0.00
Cerus (CERS) United States $0.759B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.755B 21.17
Quanterix (QTRX) United States $0.742B 0.00
TG Therapeutics (TGTX) United States $0.704B 0.00
LeMaitre Vascular (LMAT) United States $0.574B 27.78
Surmodics (SRDX) United States $0.544B 79.10
OraSure Technologies (OSUR) United States $0.532B 24.51
Meridian Bioscience (VIVO) United States $0.487B 14.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.392B 0.00
Vapotherm (VAPO) United States $0.354B 0.00
Utah Medical Products (UTMD) United States $0.321B 22.26
BioLife Solutions (BLFS) United States $0.318B 99.59
Zynex (ZYXI) United States $0.277B 28.53
Bovie Medical (APYX) United States $0.237B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.200B 4.24
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.175B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Female Health (VERU) United States $0.145B 0.00
Fonar (FONR) United States $0.139B 7.30
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.093B 20.56
Surface Oncology (SURF) United States $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 20.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00